# NCT05236946 (NCT05236946)

> Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05236946
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Tata Memorial Hospital
- Conditions: Asymptomatic Brain Metastases; Driver Mutation Positive Non-small Cell Lung Cancer
- Interventions: Stereotactic radiosurgery/whole brain radiotherapy; Tyrosine kinase inhibitor
- Enrollment: 190
- Primary outcome: Intracranial progression free survival at 24 months

## Commentary we found

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct05236946